| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 55.25B | 55.48B | 51.06B | 81.53B | 61.79B | 39.74B |
| Gross Profit | 11.95B | 6.92B | 3.87B | 31.32B | 19.81B | 4.04B |
| EBITDA | 11.81B | 13.39B | 11.37B | 36.96B | 24.48B | 8.68B |
| Net Income | 4.88B | 6.11B | 3.82B | 29.20B | 17.94B | 2.85B |
Balance Sheet | ||||||
| Total Assets | 88.73B | 87.70B | 82.58B | 93.68B | 72.27B | 56.12B |
| Cash, Cash Equivalents and Short-Term Investments | 6.99B | 24.04B | 6.70B | 11.00B | 11.84B | 5.87B |
| Total Debt | 18.71B | 16.48B | 14.81B | 15.64B | 15.34B | 15.37B |
| Total Liabilities | 31.19B | 29.75B | 27.49B | 28.65B | 26.68B | 25.26B |
| Stockholders Equity | 56.43B | 56.92B | 54.03B | 63.99B | 44.51B | 29.85B |
Cash Flow | ||||||
| Free Cash Flow | 6.13B | 7.21B | 6.00B | 30.31B | 19.05B | 6.51B |
| Operating Cash Flow | 11.66B | 11.41B | 9.64B | 34.48B | 22.02B | 7.83B |
| Investing Cash Flow | -3.82B | -7.92B | 4.08B | -21.62B | -8.34B | -1.02B |
| Financing Cash Flow | -7.35B | -3.50B | -16.80B | -14.13B | -7.90B | -5.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | $34.00B | 7.36 | 8.70% | 9.71% | 4.98% | 37.22% | |
81 Outperform | $1.82B | 3.97 | 13.16% | 3.64% | 3.82% | -13.73% | |
77 Outperform | $4.56B | 11.14 | 16.38% | 1.13% | 1.88% | 9.30% | |
76 Outperform | $1.87B | 6.19 | 14.98% | 2.94% | -29.82% | -16.77% | |
76 Outperform | $1.60B | 6.34 | 8.36% | 0.39% | -1.33% | -33.66% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | $2.57B | 2.57 | 25.25% | 20.35% | 1.63% | -30.30% |